1. Батюшин М.М., Дмитриева О.В., Терентьев В.П., Давиденко К.С. Расчетные методы прогнозирования риска развития анальгетического интерстициального поражения почек. Тер. архив. 2008; 6: 62–5.
2. Батюшин М.М., Мационис А.Э., Повилайтите П.Е. и др. Клинико-морфологический анализ лекарственных поражений почек при терапии нестероидными противовоспалительными препаратами. Нефрология и диализ. 2009; 1: 44–9.
3. Bomback AS, Markowitz GS. Increased prevalence of acute interstitial nephritis: more disease or simply more detection? Nephrol Dial Transplant 2013; 28 (1): 16–8.
4. Clarkson MR, Giblin L, O’Connell FP et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004; 19 (11): 2778–83.
5. Blatt AE, Liebman SE. Drug-induced acute kidney injury. Hosp Med Clin 2013; 2 (4): e525–e541.
6. Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (Suppl.) 2012; 2: 1–126.
7. Cerda J, Lameire N, Eggers P et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 2008; 3 (3): 881–6.
8. Huerta C, Castellsague J, Varas-Lorenzo C et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005; 45 (3): 531–9.
9. Khanna D, Fitzgerald JD, Khanna PP et al. 2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia. Arthritis Care Res 2012; 64 (10): 1431–46.
10. Khanna D, Fitzgerald JD, Khanna PP et al. 2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Anti-inflammatory Prophylaxis of Acute Gouty Arthritis. Arthritis Care Res 2012; 64 (10): 1447–61.
11. Leblanc M, Kellum JA, Gibney RT et al. Risk factors for acute renal failure: inherent and modifiable risks. Curr Opin Crit Care 2005; 11 (6): 533–6.
12. Leonard CE, Freeman CP, Newcomb CW et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute in-terstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf 2012; 21: 1155–72.
13. Lopez-Novoa JM, Quiros Y, Vicente L et al. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 79 (1): 33–45.
14. Mehta RL, Pascual MT, Soroko S et al. Program to Improve Care in Acute Renal Disease (PICARD). Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004; 66: 1613–21.
15. Muriithi AK, Leung N, Valeri AM et al. Biopsy-Proven Acute Intersti-tial Nephritis, 1993-2011: A Case Series. Am J Kidney Dis 2014; 64 (4): 558–66.
16. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med 2008; 36 (4): S216–S223.
17. Pallet N, Djamali A, Legendre C. Challenges in diagnosing acute calcineurininhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers. Pharm Res 2011; 64 (1): 25–30.
18. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010; 6: 461–70.
19. Preddie DC, Markowitz GS, Radhakrishnan J et al. Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol 2006; 1 (4): 718–22.
20. Prowle JR, Echeverri JE, Ligabo EV et al. Fluid balance and acute kid-ney injury. Nat Rev Nephrol 2010; 6: 107–15.
21. Prowle JR, Chua HR, Bagshaw SM, Bellomo R. Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury – a systematic review. Crit Care 2012; 16: 230.
22. Simpson IJ, Marshall MR, Pilmore H et al. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton) 2006; 11 (5): 381–5.
23. Sierra F, Suarez M, Rey M, Vela MF. Systematic review: proton pump inhibitor-associated acute interstitial nephritis. Aliment Pharmacol Ther 2007; 26 (4): 545–53.
24. Schneider V, Levesque LE, Zhang B et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a populationbased, nested case-control analysis. Am J Epidemiol 2006; 164 (9): 881–9.
25. Schwarz A, Krause P-H, Kunzendorf U et al. The outcome of acute in-terstitial nephritis: Risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000; 54 (3): 179–90.
26. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically Ill patients: a Multinational, Multicenter Study. JAMA 2005; 294 (7): 813–8.
27. Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Eur J Intern Med 2015; 26: 285–91.
28. Wang HE, Muntner P, Chertow GM et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012; 35 (4): 349–55.

М.М.Батюшин

ФГБОУ ВО Ростовский государственный медицинский университет Минздрава России